Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Gentamicin for Herlitz Junctional Epidermolysis Bullosa
NCT04140786Phase 2Unknown
- Sponsor
- University of Southern California
- Start
- Oct 2019
- Primary completion
- Nov 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of gentamicin in junctional epidermolysis bullosa (JEB), sponsored by University of Southern California. Status: unknown.
02
Drugs
gentamicin
03
Conditions
junctional epidermolysis bullosa (JEB)
Beyond the preview
Go deeper on NCT04140786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140786.